Mathias Bruyand

1.9k total citations
35 papers, 1.1k citations indexed

About

Mathias Bruyand is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Mathias Bruyand has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 12 papers in Epidemiology and 9 papers in Virology. Recurrent topics in Mathias Bruyand's work include Pneumocystis jirovecii pneumonia detection and treatment (10 papers), HIV/AIDS Research and Interventions (10 papers) and HIV Research and Treatment (9 papers). Mathias Bruyand is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (10 papers), HIV/AIDS Research and Interventions (10 papers) and HIV Research and Treatment (9 papers). Mathias Bruyand collaborates with scholars based in France, Denmark and United Kingdom. Mathias Bruyand's co-authors include François Dabis, Geneviève Chêne, Fabrice Bonnet, Henriette de Valk, P. Mercié, Stéphane Bonacorsi, C. Greib, D. Neau, Jens Lundgren and Patricia Mariani‐Kurkdjian and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

Mathias Bruyand

33 papers receiving 1.1k citations

Peers

Mathias Bruyand
Saverio Giuseppe Parisi Italy
David Dalmau Spain
Christophe Michon France
Shelly J. Krebs United States
J. T. Brooks United States
Ruth Berggren United States
Helmut Schöfer Germany
Amedeo Capetti Italy
Shalini Duggal India
F Parras Spain
Saverio Giuseppe Parisi Italy
Mathias Bruyand
Citations per year, relative to Mathias Bruyand Mathias Bruyand (= 1×) peers Saverio Giuseppe Parisi

Countries citing papers authored by Mathias Bruyand

Since Specialization
Citations

This map shows the geographic impact of Mathias Bruyand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Bruyand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Bruyand more than expected).

Fields of papers citing papers by Mathias Bruyand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Bruyand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Bruyand. The network helps show where Mathias Bruyand may publish in the future.

Co-authorship network of co-authors of Mathias Bruyand

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Bruyand. A scholar is included among the top collaborators of Mathias Bruyand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Bruyand. Mathias Bruyand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruyand, Mathias, Patricia Mariani‐Kurkdjian, Simon Le Hello, et al.. (2019). Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016. Eurosurveillance. 24(8). 47 indexed citations
2.
Ingelbeen, Brecht, Mathias Bruyand, Simon Le Hello, et al.. (2018). Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups. PLoS ONE. 13(11). e0207492–e0207492. 16 indexed citations
3.
Bruyand, Mathias, Patricia Mariani‐Kurkdjian, Malika Gouali, et al.. (2017). Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection. Médecine et Maladies Infectieuses. 48(3). 167–174. 80 indexed citations
4.
Podlekareva, Daria, Anna Schultze, Frank A. Post, et al.. (2016). Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study. The Lancet HIV. 3(3). e120–e131. 43 indexed citations
5.
Moisan, Frédéric, et al.. (2016). Public health structures attendance during the Ebola outbreak in Guéckédou, Guinea. Epidemiology and Infection. 144(11). 2338–2344. 6 indexed citations
6.
Bruyand, Mathias, A. Lavolé, Karen Leffondré, et al.. (2015). Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients. AIDS. 29(9). 1105–1109. 7 indexed citations
7.
Bruyand, Mathias, Lene Ryom, Leah Shepherd, et al.. (2015). Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 68(5). 568–577. 31 indexed citations
8.
9.
Vandenhende, Marie-Anne, Pantxika Bellecave, Patrícia Recordon-Pinson, et al.. (2014). Prevalence and Evolution of Low Frequency HIV Drug Resistance Mutations Detected by Ultra Deep Sequencing in Patients Experiencing First Line Antiretroviral Therapy Failure. PLoS ONE. 9(1). e86771–e86771. 35 indexed citations
10.
Richert, Laura, P. Mercié, Frédéric‐Antoine Dauchy, et al.. (2014). Decline in locomotor functions over time in HIV-infected patients. AIDS. 28(10). 1441–1449. 40 indexed citations
11.
Podlekareva, Daria, Daniel Grint, Frank A. Post, et al.. (2013). Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe. European Respiratory Journal. 43(1). 166–177. 25 indexed citations
12.
Podlekareva, Daria, Daniel Grint, Frank A. Post, et al.. (2013). Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients. The International Journal of Tuberculosis and Lung Disease. 17(2). 198–206. 8 indexed citations
13.
Petoumenos, Kathy, Signe Westring Worm, Éric Fontas, et al.. (2012). Predicting the short‐term risk of diabetes in HIV‐positive patients: the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study. Journal of the International AIDS Society. 15(2). 17426–17426. 53 indexed citations
14.
Bonnet, Fabrice, Hélène Amieva, Fabienne Marquant, et al.. (2012). Cognitive disorders in HIV-infected patients. AIDS. 27(3). 391–400. 113 indexed citations
15.
16.
Moutel, Grégoire, F. Raffi, François Dabis, et al.. (2011). Information That Should Be Given to HIV Cohort Participants during Ongoing Research: The Viewpoints of Patient Representatives and Research Professionals. Journal of Empirical Research on Human Research Ethics. 6(4). 76–83. 4 indexed citations
17.
Richert, Laura, Patrick Dehail, P. Mercié, et al.. (2011). High frequency of poor locomotor performance in HIV-infected patients. AIDS. 25(6). 797–805. 63 indexed citations
18.
Worm, Signe Westring, Nina Friis‐Møller, Mathias Bruyand, et al.. (2010). High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. AIDS. 24(3). 427–435. 67 indexed citations
19.
Receveur, M. C., Mathias Bruyand, Thierry Pistone, & Denis Malvy. (2009). Vaccination antiamarile : mise au point à propos des effets indésirables rares et graves. Médecine et Maladies Infectieuses. 39(4). 234–241. 2 indexed citations
20.
Bruyand, Mathias, et al.. (2008). Vaccination contre la fièvre jaune en dehors des sujets immunocompétents. Médecine et Maladies Infectieuses. 38(10). 524–532. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saverio Giuseppe Parisi Breakdown of academic impact, for papers by David Dalmau Breakdown of academic impact, for papers by Christophe Michon Breakdown of academic impact, for papers by Shelly J. Krebs Breakdown of academic impact, for papers by J. T. Brooks Breakdown of academic impact, for papers by Ruth Berggren Breakdown of academic impact, for papers by Helmut Schöfer Breakdown of academic impact, for papers by Amedeo Capetti Breakdown of academic impact, for papers by Shalini Duggal Breakdown of academic impact, for papers by F Parras
Rankless by CCL
2026